BD to Introduce Integrated Medication Management Platform Designed to Address Hospitals’ Greatest Challenges at #ASHP17
New BD HealthSightTM Platform for Enterprise Medication Management Takes System-Wide Approach to Make Medication Management Safer, Simpler and Smarter
FRANKLIN LAKES, N.J., Nov. 16, 2017 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, will launch its latest advancement in comprehensive medication management, BD HealthSight™ platform for enterprise medication management, which offers a unique combination of connective technologies, analytics and expert services at this year's American Society of Health-System Pharmacists (ASHP) 2017 Midyear Meeting being held in Orlando from Dec. 3-7.
With direct medical costs associated with medication errors reaching $21 billion worldwide, innovative strategies must be developed to address the grand health challenges associated with medication management.1 BD has been evolving its focus to re-invent medication management with integration of the company’s technologies, analytics and expert services that aim to close the communication gaps across disparate solutions. The BD HealthSight platform connects systems and processes to help hospitals and health systems drive a safer, more efficient medication management process.
“The BD HealthSight platform is a response to the evolving challenges hospitals and health systems face as they work to address the complex, systemic issues associated with medication management across their enterprise,” said Ranjeet Banerjee, worldwide president of Medication Management Solutions for BD. “The BD HealthSight platform creates an ecosystem that unifies BD’s leading technologies, such as BD Pyxis™ dispensing and BD Alaris™ infusion solutions — with each other and with the hospital’s EMR provider — while also integrating advanced data and analytics with supporting practice improvement services backed by clinical experts to help optimize the entire medication management process.”
With prescription expenditure in clinics and hospitals soaring to $63.7 billion last year alone (an 11.9 percent increase from 2015)2 hospitals and health systems require a tailored, multidisciplinary approach to medication management that will enable full visibility of their facility’s medications at all times. The BD HealthSight platform introduces four primary capabilities to help improve medication visibility and safety while reducing cost across the continuum of care:
- Advanced Analytics: In order to achieve a safer, more efficient medication process, hospitals and health systems need visibility into critical data points that can help drive clinical decision making for improved outcomes. With the BD HealthSight platform and its suite of advanced analytic solutions, hospitals and health systems receive actionable data including comparative benchmarking and medication inventory optimization through a single portal to help improve safety and efficiency.
- Practice Improvement: A comprehensive medication management system can achieve optimal performance when users have access to professional services and support that can help them adopt and optimize their technology investments. The BD HealthSight platform enables a broad range of education and practice improvement services to provide hospitals and health systems with access to BD tools, resources and services to help optimize their medication management process in an effort to improve outcomes.
- Workflow Applications: Smart, practical tools help create more efficient and responsive medication management workflows from central pharmacy to the patient bedside. The BD HealthSight platform and its collection of applications can create customized dashboards to help guide decision making by prioritizing workflows that improve pharmacy response to critical medication needs on the patient floor, such as the replenishment of continuous infusions and centralized management of medication formularies that can reduce the manual maintenance of these databases.
- Common Infrastructure: The BD HealthSight’s platform standardized technical infrastructure enables centralized enterprise-wide reporting across all BD products and seamless connectivity between BD Pyxis and BD Alaris technologies as well as with the hospital’s EMR. This approach also delivers enhanced product security and advanced tools to help simplify and streamline implementation and ongoing support.
BD to Introduce New BD HealthSight Platform @ #ASHP17. Learn more about enterprise #medicationmanagement at ASHP, BD Booth #721 Tweet
With the goal of operational excellence and patient safety, Ochsner Medical Center engaged with BD as an early adopter of the BD HealthSight practice improvement services and analytics. “We have accomplished impressive optimization results in just six months. The new approach will not only revolutionize the way we function at Ochsner and across other health systems, but also revolutionize how we work to continuously improve operations and outcomes with inventory optimization analytics and services,” said Neil Hunter, Assistant Director-Pharmacy Operations at Ochsner Medical Center.
To hear from more hospitals and health systems visit bd.com/healthsight. To register for any of the BD-sponsored activities at ASHP, please visit bd.com/ashp2017 and be sure to visit BD at ASHP, Booth #721 and follow us on Twitter @BDandCo.
BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues. BD has nearly 50,000 associates across 50 countries who work in close collaboration with customers and partners to help enhance outcomes, lower health care delivery costs, increase efficiencies, improve health care safety and expand access to health. For more information on BD, please visit bd.com.
BD Public Relations
Monique N. Dolecki
BD Investor Relations
1 New England Health Institute. Preventing medication errors: a $21 billion opportunity. www.nehi.net/bendthecurve/sup/
documents/Medication_Errors_%20Brief.pdf. Accessed Oct. 10, 2017
2 American Journal of Health-System Pharmacy. National trends in prescription drug expenditures and projections for 2017. Vol. 74; Number 15. August 2017; 1158-1173. Accessed Oct. 16, 2017